Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	7.71	102.48	95.14
Graham Fair Price	4.54	46.78	44.74
PEG	8373.67	7.03	0.08
Price/Book	-6.06	4.36	4.65
Price/Cash Flow	-49.69	42.82	85.11
Prices/Earnings	-11.34	42.48	47.91
Price/Sales	-4.42	28.52	29.84
Price/FCF	-49.69	42.82	85.11
Naive Interpretation	member

01 - Valuation · Bad

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	-0.71	0.76	0.77
Operating Margin	7.14	0.19	0.17
ROA	10.03	0.02	0.01
ROE	0.02	0.03	5.95
ROIC	0.02	0.02	-1.53
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	< 0.005	-0.10	94.32
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	2.53	0.05	-97.88
EPS QOQ	5.77	0.06	-98.95
FCF QOQ	27.31	0.87	-96.82
Revenue QOQ	0.19	-0.02	-91.04
Naive Interpretation	member

03 - Financial Growth · Bad

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	79.82	77.64	-2.73
Days Sales Outstanding (DSO)	110.61	42.11	-61.93
Inventory Turnover	1.13	1.16	2.81
Debt/Capitalization	0.17	0.17	-0.52
Quick Ratio	0.96	0.95	-1.42
Naive Interpretation	member

04 - Leverage & Liquidity · Bad

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	60.58	61.53	1.56
Cash	14.42	18.22	26.35
Capex	-0.15	-0.17	-12.55
Free Cash Flow	3.31	6.27	89.65
Revenue	9.43	9.42	-0.18
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	1.09	1.11	1.31
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	1.39	1.00	-28.43
Naive Interpretation	Member

06 - Financial Health · Bad

Rating